Reduced versus maximum tolerated methotrexate dose concomitant with adalimumab in patients with rheumatoid arthritis (MIRACLE): a randomised, open-label, non-inferiority trial - The Lancet Rheumatology
Fab Fc Fv
Comparison of consistency and complementarity of reporting biosimilar quality attributes between regulatory and scientific communities: An adalimumab case study - ScienceDirect
IJMS | Free Full-Text | Pharmacogenomics of Anti-TNF Treatment Response Marks a New Era of Tailored Rheumatoid Arthritis Therapy
Adalimumab in the treatment of arthritis | Semantic Scholar
Anti-TNF-α biotherapies: perspectives for evidence-based personalized medicine | Immunotherapy
Patient perspectives of successful adalimumab biosimilar transitioning in Crohn's disease: an interview study
3 Adalimumab
Construct of pOptiVEC-HC adalimumab, containing the sequence of... | Download Scientific Diagram
Implications for sequencing of biologic therapy and choice of second anti‐TNF in patients with inflammatory bowel disease: results from the IMmunogenicity to Second Anti‐TNF therapy (IMSAT) therapeutic drug monitoring study - Chanchlani -
Biomolecules | Free Full-Text | Anti-TNF Alpha Antibody Humira with pH-dependent Binding Characteristics: A constant-pH Molecular Dynamics, Gaussian Accelerated Molecular Dynamics, and In Vitro Study
Peptide Mapping LC-MS/MS Analysis Workflow for Adalimumab
PPMS onset upon adalimumab treatment extends the spectrum of anti-TNF-α therapy-associated demyelinating disorders - Sinah Engel, Felix Luessi, Aneka Mueller, Rudolf E. Schopf, Frauke Zipp, Stefan Bittner, 2020
Structural Biology of the TNF Antagonists Used in the Treatment of Rheumatoid Arthritis
Analysis of Monoclonal Antibodies in Human Serum as a Model for Clinical Monoclonal Gammopathy by Use of 21 Tesla FT-ICR Top-Down and Middle-Down MS/MS | SpringerLink
EP3009450A1 - Liquid formulation comprising adalimumab and an acetate buffer - Google Patents
IJMS | Free Full-Text | Structural Biology of the TNFα Antagonists Used in the Treatment of Rheumatoid Arthritis
Adalimumab: Uses, Interactions, Mechanism of Action | DrugBank Online
Human Anti-TNF-alpha IgG4 antibody | InvivoGen
RCSB PDB - 6CR1: adalimumab EFab
_[Adalimumab_Biosimilar_3].png "JAN: Japanese Accepted Names for Pharmaceuticals")